- Report
- November 2024
- 230 Pages
Global
From €4861EUR$5,550USD£4,219GBP
- Report
- August 2019
Global
€2584EUR$2,950USD£2,242GBP
- Report
- April 2024
- 95 Pages
Global
From €4335EUR$4,950USD£3,763GBP
- Report
- July 2025
- 200 Pages
Japan
From €2181EUR$2,490USD£1,893GBP
- Report
- July 2025
- 200 Pages
Japan
From €2181EUR$2,490USD£1,893GBP
- Report
- January 2025
- 150 Pages
Global
From €2181EUR$2,490USD£1,893GBP
- Report
- November 2024
- 150 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- August 2024
- 120 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- August 2024
- 120 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- January 2025
- 128 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- February 2025
- 125 Pages
United States
From €2181EUR$2,490USD£1,893GBP
- Report
- December 2024
- 130 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- October 2024
- 145 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- July 2024
- 172 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- January 2025
- 191 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- August 2024
- 147 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- June 2024
- 145 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- April 2023
- 61 Pages
Global
From €3503EUR$4,000USD£3,041GBP
- Report
- November 2023
- 178 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- August 2023
- 78 Pages
Israel
From €3065EUR$3,500USD£2,661GBP

The Cardiac Valve market is a segment of the Cardiovascular Devices industry, which includes a range of products used to diagnose and treat heart conditions. Cardiac valves are used to regulate the flow of blood through the heart, and can be either mechanical or biological. Mechanical valves are typically made of metal and are designed to last for many years, while biological valves are made of animal tissue and are designed to be replaced over time. Both types of valves are used to treat a variety of heart conditions, including aortic stenosis, mitral regurgitation, and tricuspid regurgitation.
The Cardiac Valve market is highly competitive, with a number of companies offering a range of products. Major players in the market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and LivaNova. Other companies in the market include CryoLife, Symetis, and Neovasc. Show Less Read more